Testimony

Dec 13, 2017
AHA statement before the Health Subcommittee on Energy & Commerce regarding examing the drug supply chain.
Nov 8, 2017
AHA comments on the implementation of alternative payment models (APMs) in the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.
Oct 25, 2017
AHA Statement for House Energy and Commerce Committee Hearing on Opioids
Oct 5, 2017
AHA Statement before the U.S. Senate Committee on Health, Education, Labor and Pensions regarding the Federal response to the opioid crisis.
Sep 25, 2017
AHA statement to the Senate Committee on Finance regarding he importance of maintaining coverage and access to care as the Senate considers a proposal that would radically transform the health care system.
Jul 18, 2017
AHA to the Subcommittee on Oversight and Investigations Committee on Energy and Commerce regarding the 340B program.
Jul 17, 2017
AHA urges retention of certain key tax code provisions related to section 501(c)(3) hospitals as the Senate works to reform the current tax code.
Jun 13, 2017
AHA statement for the record regarding the challenges associated with the cost of prescription drugs and the implications for patients and the health care delivery system.